Cyclopharm (ASX:CYC) announces the first signed U.S. contract for Technegas with Duke University Hospital following approval of by the USFDA on 29 September 2023 | ASX Announcement: https://announcements.asx.com.au/asxpdf/20231205/pdf/05y66m6jl37slv.pdf #CYC #USA #Technegas #shorts
AEV
0.009
50%
KFM
0.061
-21.8%
VTA
0.021
31.3%
CMO
0.004
-20%
HIQ
0.005
25%
SRJ
0.004
-20%
VKA
0.011
22.2%
DTZ
0.026
-18.8%
WCN
0.023
21.1%
TZN
0.019
-17.4%
A8G
0.21
20%
FAU
0.01
-16.7%
MGU
0.006
20%
PL9
0.005
-16.7%
ABE
0.037
19.4%
UNT
0.005
-16.7%
JAV
0.097
18.3%
BRY
0.011
-15.4%
HMD
0.039
18.2%
CMP
0.235
-14.5%
SLA
0.13
18.2%
AGN
0.15
-14.3%
NYM
0.053
17.8%
GEN
0.006
-14.3%
EAU
0.14
16.7%
LRM
0.018
-14.3%
INF
0.007
16.7%
M4M
0.006
-14.3%
XST
0.014
16.7%
X2M
0.006
-14.3%
KLI
0.325
16.1%
SLB
0.275
-14.1%
HVY
0.4
15.9%
NOX
0.065
-13.3%
REC
0.037
15.6%
AS2
0.007
-12.5%
AHE
0.015
15.4%
AUV
0.007
-12.5%
DRX
0.016
14.3%
MRD
0.042
-12.5%
